Skip to main content
. 2024 Jan 22;14(1):71. doi: 10.3390/metabo14010071
Alanine aminotransferase (ALT)
Androgen receptors (ARs)
Aspartate aminotransferase (AST)
Atrazine (ATZ)
Body mass index (BMI)
Plasticizers bisphenol A (BPA)
Bisphenol A (BPA)
Confidence interval (CI)
Credible interval (CrI)
Cypermethrin (CYP)
Cytochrome P450 (CYP)
Organochlorines dichlorodiphenyltrichloroethane (DDT)
Phthalates di-2-ethylhexyl phthalate (DEHP)
Developmental Origins of Health and Disease (DOHaD)
Estrone (E1)
17-β-estradiol (E2)
Estriol (E3)
European Chemicals Agency (ECHA)
Endocrine-disrupting chemicals (EDCs)
Ethinylestradiol (EE2)
European Food Safety Authority (EFSA)
Protection Agency (EPA)
Estrogen receptors (ERα and ERβ)
Free Fatty Acids (FFAs)
Farnesoid X α receptor (FXRα)
Gamma-glutamyl transferase (GGT)
Hepatitis C Virus virus (HCV)
High-density lipoprotein (HDL)
Janus kinase 2/Signal Transducer and Transcription Activator 5 (JAK2/STAT5)
Lipid accumulation product (LAP)
Low birth weight (LBW)
Liver X receptors α and β (LXR)
Steatohepatitis associated with metabolic dysfunction (MASH),
Metabolic dysfunction-associated steatotic liver disease (MASLD)
Mono-(2-ethylhexyl) phthalate (MEHP)
Monoethyl phthalate (MEP)
Mono-(2-ethylhexyl) phthalate (MEPH)
Metabolite mono-(2-ethylhexyl) phthalate (MEPH)
Nonalcoholic fatty liver disease (NAFLD)
Non-alcoholic Steatosteato-hepatitis (NASH)
Dioxin-like (DL) and non-dioxin-like (NDL)
Dioxin-like (DL) and non-dioxin-like (NDL)
Nonylphenols (NPs)
Occhlorinated dibenzodioxin (OCDD)
Odds ratio (OR)
Polycyclic aromatic hydrocarbons (PAHs)
Polybrominated diphenyl ethers (PBDEs)
2-polybrominated diphenyl ethers (PBDEs)
Polychlorinated biphenyls (PCBs)
Perfluoroalkyl substances (PFAS)
Fluorinated chemicals (PFCs)
Perfluorohexane sulfonic acid (PFHxS)
Perfluorooctanoic acid (PFOA)
Organotins tributyltin polyfluoroalkyls and/or perfluorooctane sulfonate (PFOS)
Perfluorooctane sulfonate (PFOS)
Persistent Organic Pollutants (POPs)
Peroxisome proliferators (PPARs)
Peroxisome proliferator-activated γ receptor (PPARγ)
Progesterone receptors (PRs)
Retinoic receptor isoforms (RARα and RARγ)
Retinoid X receptors (RXRα, RXRβ, and RXRγ)
Retinoid α X receptor (RXRα)
Steroid receptor coactivator complexes (SRCs)
Type 2 diabetes mellitus (T2DM)
Triacylglyceride (TAG)
Thyroid receptors (TR)
Thyroid α receptor isoforms (TRα)
UDP-glucuronosyltransferase (UGT)
Visceral adiposity index (VAI)
Very Low-Density Lipoprotein VLDL